吉利德科学

US · GILD #110 按市值排名上市于 1992

156.19 -1.18 -0.75%

实时 - 追踪5344个代码 - 心跳于527秒前 · 2026-10-16 20:02

✦ 量化股权信号计算方式说明

减持

最近一期（2026/Q3）披露持股的机构数量减少了4家。
机构持股总比例基本持平。

机构持股

机构持股比例: 91.29% -0.07pp
机构数量: 2,709 -4
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund77.66%

Public Company4.16%

Government Pension Fund2.47%

Hedge Fund2.14%

Private Company2.03%

Sovereign Wealth Fund1.86%

Insurance Company0.32%

Corporate Pension Plan0.21%

Family Office/Trust0.18%

Other8.96%

主要股东截至 2026-06-30

BlackRock 9.83% · 121.84M 股

Vanguard Capital Management, LLC 7.10% · 88.06M 股

State Street Global Advisors 4.94% · 61.22M 股

Capital Research 4.90% · 60.79M 股

FMR 4.75% · 58.95M 股

Other 68.48%

Invesco Capital Management LLC 3.01% · 37.34M 股

Vanguard Portfolio Management, LLC 2.85% · 35.32M 股

T. Rowe Price Group, Inc. 2.44% · 30.27M 股

Geode Capital Management, LLC 2.42% · 30.07M 股

Dodge & Cox 1.91% · 23.68M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 18次买入 · 32次卖出

姓名	职务	持股比例
Daniel Patrick O'Day	Chairperson & CEO	0.05%
Andrew Dickinson	Chief Financial Officer	0.01%
Johanna Mercier	Chief Commercial Officer	0.01%
Diane Wilfong	Former Senior VP, Corporate Controller & Chief Accounting Officer	0.00%
Deborah Telman	Executive VP of Corporate Affairs, General Counsel & Corporate Secretary	0.00%
Sandra Patterson	Senior VP, Corporate Controller & Principal Accounting Officer	0.00%
Jacqueline Barton	Independent Director	0.00%
Dietmar Berger	Chief Medical Officer	0.00%
Harish Manwani	Independent Director	0.00%
Javier Rodriguez	Independent Director	0.00%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-30	Daniel Patrick O'Day	Chairperson & CEO	Automatic Disposition	-15,000	$147.72–148.63
2026-09-21	Erin Burkhart	SVP, Controller & Principal Accounting Officer	Derivative Exercise and Sale	-768	$152.67
2026-09-21	Erin Burkhart	SVP, Controller & Principal Accounting Officer	Derivative Exercise and Retained	+1,455	--
2026-09-14	Andrew Dickinson	Chief Financial Officer	Automatic Disposition	-3,000	$145.29
2026-09-14	Johanna Mercier	Chief Commercial Officer	Automatic Disposition	-3,000	$143.69–145.29
2026-09-09	Andrew Dickinson	Chief Financial Officer	Derivative Exercise and Sale	-1,347	$144.81
2026-09-09	Andrew Dickinson	Chief Financial Officer	Derivative Exercise and Retained	+1,450	--
2026-09-09	Daniel Patrick O'Day	Chairperson & CEO	Derivative Exercise and Sale	-4,230	$144.81
2026-09-09	Daniel Patrick O'Day	Chairperson & CEO	Derivative Exercise and Retained	+4,550	--
2026-09-09	Johanna Mercier	Chief Commercial Officer	Derivative Exercise and Sale	-1,347	$144.81
2026-09-09	Johanna Mercier	Chief Commercial Officer	Derivative Exercise and Retained	+1,450	--
2026-09-09	Dietmar Berger	Chief Medical Officer	Derivative Exercise and Sale	-263	$144.81
2026-09-09	Dietmar Berger	Chief Medical Officer	Derivative Exercise and Retained	+270	--
2026-09-09	Keeley M. Wettan	Executive VP and General Counsel of Legal & Compliance	Derivative Exercise and Sale	-285	$144.81
2026-09-09	Keeley M. Wettan	Executive VP and General Counsel of Legal & Compliance	Derivative Exercise and Retained	+305	--
2026-08-31	Daniel Patrick O'Day	Chairperson & CEO	Automatic Disposition	-15,000	$147.51–149.38
2026-08-25	Anthony Welters	Independent Director	Derivative Exercise and Sale	-18,000	$60.67–148.82
2026-08-19	Jeffrey Bluestone	Independent Director	Derivative Exercise and Sale	-5,000	$61.35–146.36
2026-08-16	Andrew Dickinson	Chief Financial Officer	Automatic Disposition	-3,000	$138.36
2026-08-16	Johanna Mercier	Chief Commercial Officer	Automatic Disposition	-3,000	$138.04

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:02:15 · 仅供参考，不构成投资建议，也未考虑您的具体情况。